Evaluation of a novel epi-virotherapeutic treatment strategy of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus

DSpace Repository

Evaluation of a novel epi-virotherapeutic treatment strategy of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus

Author: Ellerhoff, Tim Patrick
Tübinger Autor(en):
Ellerhoff, Tim Patrick
Other Contributors: Eberhard Karls Universität Tübingen
Issue year: 2017
Verlagsangabe: Tübingen
Language: English
Full text: http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-790896
DDC Classifikation: 610 - Medicine and health
Dokumentart: PhDThesis
Pages: 93 Seiten : Illustrationen
Reference: 496089358
496088904
Note: Dissertation, Eberhard Karls Universität Tübingen, 2017; Erscheint auch als, Online-Ausgabe, Ellerhoff, Tim Patrick, Evaluation of a novel epi-virotherapeutic treatment strategy of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus, Tübingen, 2017, 1 Online-Ressource (93 Seiten),
Show full item record

This item appears in the following Collection(s)